Q32 Bio Inc. (QTTB) Research & Development (2017 - 2026)

Q32 Bio has reported Research & Development for 10 years, with the latest figure at $4.3 million in Q2 2026.

• On a quarterly basis, Research & Development fell 17.48% year-over-year to $4.3 million in Q2 2026; TTM through Jun 2026 was $14.3 million, a 61.41% decrease from a year earlier, with the FY2025 full-year figure at $19.2 million, down 60.21% from the prior year.
• Research & Development was $4.3 million for Q2 2026 at Q32 Bio, up from $3.2 million in the prior quarter.
• The five-year high for Research & Development was $27.1 million in Q4 2022, with the low at $3.2 million in Q1 2026.
• Average Research & Development over 5 years is $11.4 million, with a median of $8.2 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Research & Development surged 92.23% in 2024, then sank 75.22% in 2025.
• Over 5 years, Research & Development stood at $27.1 million in 2022, then plunged by 69.28% to $8.3 million in 2023, then grew by 26.45% to $10.5 million in 2024, then slumped by 68.56% to $3.3 million in 2025, then increased by 28.48% to $4.3 million in 2026.
• The last three Research & Development figures came in at $4.3 million (Q2 2026), $3.2 million (Q1 2026), and $3.3 million (Q4 2025), per Business Quant data.